Neostem (NBS)

Add to Watchlists Create an Alert
0.5692 -0.01  -2.28%   AMEX May 23, 4:59PM BATS Real time Currency in USD

Neostem Revenue Quarterly:

2.751M for Dec. 31, 2012
View Full Chart

Neostem Revenue Quarterly Chart

    Neostem Historical Revenue Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 2.751M
    Sept. 30, 2012 4.434M
    June 30, 2012 3.372M
    March 31, 2012 22.06M
    Dec. 31, 2011 4.213M
    Sept. 30, 2011 2.177M
    June 30, 2011 2.211M
    March 31, 2011 19.59M
    Dec. 31, 2010 18.10M
    Sept. 30, 2010 16.48M
    June 30, 2010 19.41M
    March 31, 2010 15.83M
    Dec. 31, 2009 11.41M
    Sept. 30, 2009 0.0851M
    June 30, 2009 0.0316M
    March 31, 2009 0.0451M
    Dec. 31, 2008 0.0341M
    Sept. 30, 2008 0.0252M
    June 30, 2008 0.0235M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
       
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro
    Sept. 30, 2000 Go Pro

    About Revenues

    Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.

    While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
    Learn More

    Get data for

    NBS Revenue Quarterly Benchmarks

    Companies
    Neuralstem 0.0025M
    Pluristem Therapeutic 0.195M
    Aastrom Biosciences 0.019M

    NBS Revenue Quarterly Rankings

    Overall 43rd percentile
    4521 of 8006
    Sector 42nd percentile
    394 of 686 in Healthcare
    Industry 63rd percentile
    91 of 248 in Biotechnology

    NBS Revenue Quarterly Range, Past 5 Years

    Minimum 0.0235M Jun 2008
    Maximum 22.06M Mar 2012
    Average 7.488M